Director — Global Supply Chain End-to-End Process Capabilities

Who We Are

Bio Marin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options.

More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of Bio Marin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

Bio Marin’s Technical Operations group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the commercial market. These engineers, technicians, scientists and support staff build and maintain Bio Marin’s cutting-edge manufacturing processes and sites, provide quality assurance and quality control to ensure we meet regulatory standards, and procure the needed goods and services to support manufacturing and coordinating the worldwide movement of our drugs to patients.

The Director, Supply Chain Framework, will lead the design, standardization, and governance of Bio Marin’s end-to-end supply chain processes. This leader drives process transformation, operational consistency, and cross-market adoption while partnering across Supply Chain, Manufacturing, Clinical, and Commercial to embed best practices and deliver sustained performance improvement.

• Partner with the Global Supply Chain Leadership team to develop and maintain end-to-end process standards across Planning, Distribution, Launches, Variations, Value Chain, and Clinical Supply Chain that drive consistency, scalability, and alignment with corporate standards.
• Manage changes to these processes through clearly defined approval gates and compliance checks, aligned with global design principles and applicable GxP/regulatory requirements.
• Build and sustain the frameworks, documentation, and governance routines that keep processes auditable, transparent, and audit-ready.
• Serve as the global process authority for end-to-end supply chain process, with accountability for decision governance, prioritization, and escalation across functions and regions.

• Lead the Supply Chain end-to-end process redesign initiatives aimed at improving efficiency, quality, and agility throughout the supply chain in its current scope.
• Partner with Digital and Analytics teams to integrate advanced technologies and data-driven solutions into core processes for Supply Chain scope.
• Continuously identify bottlenecks and implement structured improvement plans that deliver measurable business impact.

• Drive implementation of new processes, ensuring seamless integration across all supply chain functions.
• Design and deliver capability-building programs, including training and change management strategies, to foster adoption.
• Monitor adherence and performance, using insights to refine processes and sustain long‑term improvements.

• Build, lead, and develop a high-performing team, including direct and dotted-line reports, responsible for process excellence, governance, capability building, and continuous improvement.
• Align process strategies with broader business objectives by collaborating with Manufacturing, Clinical, QA, Commercial, and Finance.
• Serve as a process owner and escalation point for critical issues,…